Islet transplantation using donors after cardiac death: Report of the Japan islet transplantation registry

Transplantation

Volumn 90, Issue 7, 2010, Pages 740-747

  Saito, Takuro ^a   Gotoh, Mitsukazu ^a   Satomi, Susumu ^b   Uemoto, Shinji ^c   Kenmochi, Takashi ^d   Itoh, Toshinori ^e   Kuroda, Yoshikazu ^f   Yasunami, Youichi ^g   Matsumoto, Shnichi ^h   Teraoka, Satoshi ⁱ  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d SAKURA NATIONAL HOSPITAL   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KOBE UNIVERSITY   (Japan)

^g FUKUOKA UNIVERSITY   (Japan)

^h BAYLOR RESEARCH INSTITUTE   (United States)

ⁱ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Donors after cardiac death; Islet transplantation; Multicenter trial

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C;

ARTICLE; CLINICAL ARTICLE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HUMAN; HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; C-PEPTIDE; CADAVER; CELL SEPARATION; DEATH; FEMALE; GRAFT SURVIVAL; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; JAPAN; MALE; MIDDLE AGED; ORGAN PRESERVATION; PATIENT SELECTION; REGISTRIES; REOPERATION; TISSUE DONORS; YOUNG ADULT;

EID: 77958005273     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ecb044     Document Type: Article

References (41)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid- free im-munosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005; 365: 1642.
3. Matsumoto S, Okitsu T, Iwanaga Y, et al. Follow-up study of the first successful living donor islet transplantation. Transplantation 2006; 82: 1629.
4. Sánchez-Fructuoso AI, Prats D, Torrente J, et al. Renal transplantation from non-heart beating donors: a promising alternative to enlarge the donor pool. J Am Soc Nephrol. 2000; 11:35.
5. Corlett MP, Scharp DW. The effect of pancreatic warm ischemia on islet isolation in rats and dogs. J Surg Res 1988; 45: 531.
6. Tanioka Y, Hering BJ, Sutherland DE, et al. Effect of pancreatic warm ischemia on islet yield and viability in dogs. Transplantation 1997; 64: 1637.
7. Deai T, Tanioka Y, Suzuki Y, et al. The effect of the two-layer cold storage method on islet isolation from ischemically damaged pancreas. Kobe J Med Sci 1999; 45: 191.
8. Rilo HL, Carroll PB, Trucco M, et al. Human pancreatic islet isolation from a diabetic non-heart-beating donor. Transplant Proc 1994; 26: 598.
9. Clayton HA, Swift SM, Turner JM, et al. Non-heart-beating organ donors: a potential source of islets for transplantation? Transplantation 2000; 69: 2094.
10. Markmann JF, Deng S, Desai NM, et al. The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation 2003; 75: 1423.
11. Zhao M, Muiesan P, Amiel SA, et al. Human islets derived from donors after cardiac death are fully biofunctional. Am J Transplant 2007; 7: 2318.
12. Matsumoto S, Tanaka K. Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs). J Hepatobiliary Pancreat Surg 2005; 12: 227.
13. Matsumoto S, Okitsu T, Iwanaga Y, et al. Successful islet transplantation from non-heart-beating donor pancreata using modified Ricordi islet isolation method. Transplantation 2006; 82: 460.
14. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
15. Kim SC, Han DJ, Kang CH, et al. Analysis on donor and isolation-related factors of successful isolation of human islet of Langerhans from human cadaveric donors. Transplant Proc 2005; 37: 3402.
16. Caballero-Corbalán J, Eich T, Lundgren T, Foss A, et al. No beneficial effect of two-layer storage compared to UW-storage on human islet isolation and transplantation. Transplantation 2007; 84: 864.
17. Yoshida H, OkunoH, Kamoto T, et al. Comparison of the effectiveness of ET-Kyoto with Euro-Collins and University of Wisconsin solutions in cold renal storage. Transplantation 2002; 74: 1231
18. Noguchi H, Ueda M, Hayashi S, et al. Comparison of M-Kyoto solution and histidine-tryptophan-ketoglutarate solution with a trypsin inhibitor for pancreas preservation in islet transplantation. Transplantation. 2007;84:655.
19. Senior PA, Paty BW, Cockfield SM, et al. Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. Am J Transplant 2005; 5: 2318.
20. Froud T, Baidal DA, Ponte G, et al. Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF. Cell Transplant 2006; 15: 613.
21. Monti P, Scirpoli M, Maffi P, et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand au-toreactive memory T cells. J Clin Invest 2008; 118: 1806.
22. Froud T, Yrizarry JM, Alejandro R, et al. Use of D-STAT to prevent bleeding following percutaneous transhepatic intraportal islet transplantation. Cell Transplant 2004; 13: 55.
23. Villiger P, Ryan EA, Owen R, et al. Prevention of bleeding after islet transplantation: Lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant 2005; 5: 2992.
24. Braghi S, Bonifacio E, Secchi A, et al. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allo-graft outcome in patients with type 1 diabetes. Diabetes 2000; 49: 218.
25. Rep BO, Stobbe I, Duinkerken G, et al. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 1999; 48: 484.
26. Bosi E, Braghi S, Maffi P, et al. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 2001; 50: 2464.
27. Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmu-nity associates with clinical outcome of islet cell transplantation. PLoS ONE 2008; 3: e2435.
28. Rickels MR, Kearns J, Markmann E, et al. HLA sensitization in islet transplantation. Clin Transpl 2006; 413.
29. Campbell PM, Senior PA, Salam A, et al. High risk of sensitization after failed islet transplantation. Am J Transplant 2007; 7: 2311.
30. Ferrari-Lacraz S, Berney T, Morel P, Marangon N, et al. Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation. Transplantation 2008; 86: 357.
31. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710.
32. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
33. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosup-pression: Miami experience. Am J Transplant 2005; 5: 2037.
34. Alejandro R, Barton FB, Hering BJ, et al; Collaborative Islet Transplant Registry Investigators. 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 2008; 86: 1783.
35. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
36. Bellin MD, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008; 8: 2463.
37. Matsumoto S, Yamada Y, Okitsu T, et al. Simple evaluation of engraft-ment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant Proc 2005; 37: 3435.
38. Yamada Y, Fukuda K, Fujimoto S, et al. SUIT, secretory units ofislets in transplantation: an index for therapeutic management of islet transplanted patients and its application to type 2 diabetes. Diabetes Res Clin Pract. 2006; 74: 222.
39. Nagata H, Matsumoto S, Okitsu T, et al. Procurement of the human pancreas for pancreatic islet transplantation from marginal cadaver donors. Transplantation 2006; 82: 327.
40. Tsujimura T, Kuroda Y, Avila JG, et al. Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation 2004; 78: 96.
41. Lakey JR, Kobayashi N, Shapiro AM, et al. Current human islet isolation protocol. Chuo-Ku, Osaka, Japan, Medical Review, 2004.